The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Rush, Clifford Peter
    Biochemist born in January 1968
    Individual (1 offspring)
    Officer
    2011-10-07 ~ now
    OF - Director → CIF 0
    Mr Clifford Peter Rush
    Born in January 1968
    Individual (1 offspring)
    Person with significant control
    2016-10-07 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Webb, Sean Edwin Leonard George
    Born in October 1970
    Individual (1 offspring)
    Officer
    2012-05-16 ~ now
    OF - Director → CIF 0
    Mr Sean Edwin Leonard George Webb
    Born in October 1970
    Individual (1 offspring)
    Person with significant control
    2016-10-07 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 3
    Crawford, Duncan John Knox, Dr
    Director born in November 1960
    Individual (1 offspring)
    Officer
    2020-07-24 ~ now
    OF - Director → CIF 0
    Dr Duncan John Knox Crawford
    Born in November 1960
    Individual (1 offspring)
    Person with significant control
    2020-08-04 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

ISCA BIOCHEMICALS LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Property, Plant & Equipment
3,945 GBP2023-10-31
5,022 GBP2022-10-31
Total Inventories
4,471 GBP2023-10-31
8,986 GBP2022-10-31
Debtors
15,745 GBP2023-10-31
15,864 GBP2022-10-31
Cash at bank and in hand
2,986 GBP2023-10-31
7,301 GBP2022-10-31
Current Assets
23,202 GBP2023-10-31
32,151 GBP2022-10-31
Creditors
Current
31,204 GBP2023-10-31
26,180 GBP2022-10-31
Net Current Assets/Liabilities
-8,002 GBP2023-10-31
5,971 GBP2022-10-31
Total Assets Less Current Liabilities
-4,057 GBP2023-10-31
10,993 GBP2022-10-31
Creditors
Non-current
-5,895 GBP2023-10-31
-8,734 GBP2022-10-31
Net Assets/Liabilities
-9,952 GBP2023-10-31
1,768 GBP2022-10-31
Equity
Called up share capital
300 GBP2023-10-31
300 GBP2022-10-31
Retained earnings (accumulated losses)
-10,252 GBP2023-10-31
1,468 GBP2022-10-31
Equity
-9,952 GBP2023-10-31
1,768 GBP2022-10-31
Average Number of Employees
22022-11-01 ~ 2023-10-31
22021-11-01 ~ 2022-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
3,094 GBP2023-10-31
2,855 GBP2022-10-31
Computers
10,372 GBP2023-10-31
10,372 GBP2022-10-31
Property, Plant & Equipment - Gross Cost
13,466 GBP2023-10-31
13,227 GBP2022-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,720 GBP2023-10-31
2,596 GBP2022-10-31
Computers
6,801 GBP2023-10-31
5,609 GBP2022-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
9,521 GBP2023-10-31
8,205 GBP2022-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
124 GBP2022-11-01 ~ 2023-10-31
Computers
1,192 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,316 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment
Plant and equipment
374 GBP2023-10-31
259 GBP2022-10-31
Computers
3,571 GBP2023-10-31
4,763 GBP2022-10-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
8,605 GBP2023-10-31
12,763 GBP2022-10-31
Other Debtors
Current, Amounts falling due within one year
7,140 GBP2023-10-31
3,101 GBP2022-10-31
Debtors
Current, Amounts falling due within one year
15,745 GBP2023-10-31
15,864 GBP2022-10-31
Bank Borrowings/Overdrafts
Current
2,839 GBP2023-10-31
2,769 GBP2022-10-31
Trade Creditors/Trade Payables
Current
4,709 GBP2023-10-31
5,751 GBP2022-10-31
Other Taxation & Social Security Payable
Current
66 GBP2023-10-31
-1,205 GBP2022-10-31
Other Creditors
Current
23,590 GBP2023-10-31
18,865 GBP2022-10-31
Bank Borrowings/Overdrafts
Non-current
5,895 GBP2023-10-31
8,734 GBP2022-10-31
Deferred Tax Liabilities
Accelerated tax depreciation
954 GBP2022-10-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
-1,952 GBP2023-10-31
491 GBP2022-10-31
Profit/Loss
-10,421 GBP2022-11-01 ~ 2023-10-31
-3,383 GBP2021-11-01 ~ 2022-10-31
Dividends Paid
Retained earnings (accumulated losses)
-1,299 GBP2022-11-01 ~ 2023-10-31
-3,000 GBP2021-11-01 ~ 2022-10-31
  • ISCA BIOCHEMICALS LIMITED
    Info
    Registered number 07802238
    26 Hanover Road, Heavitree, Exeter EX1 2TL
    Private Limited Company incorporated on 2011-10-07 (13 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-29
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.